Skip to main
ARDT

ARDT Stock Forecast & Price Target

ARDT Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 36%
Hold 27%
Sell 9%
Strong Sell 0%

Bulls say

Ardent Health is in a strong position for future growth and success, demonstrated by their focus on people and investments in services and technologies. The intentional service line rationalization and CMS inpatient-only list changes have positioned the company for higher-margin growth. Professional fees and payer denial trends remain stable, and the company is managing exchange headwinds well. With a strong balance sheet and differentiated joint venture strategy, Ardent Health has the potential for continued growth and long-term success.

Bears say

Ardent Health is facing several challenges that may impact its future growth, including under-penetration in the ambulatory surgery market, weak surgical volumes, and labor cost pressures. Additionally, the company may face difficulties in expanding their outpatient access points and acquiring new markets due to their current under-appreciated market position. These challenges, along with underwhelming financial performance, justify a negative outlook on the stock.

ARDT has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 36% recommend Buy, 27% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ardent Health Partners LLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ardent Health Partners LLC (ARDT) Forecast

Analysts have given ARDT a Buy based on their latest research and market trends.

According to 11 analysts, ARDT has a Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.59, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.59, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ardent Health Partners LLC (ARDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.